Contrasting Ocular Effects of Local versus Systemic Endotoxin

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 9, 2011, Pages 6472-6477

  Rosenbaum, James T ^a   Woods, April ^a   Kezic, Jelena ^a   Planck, Stephen R ^a   Rosenzweig, Holly L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RHODAMINE 6G; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TOLL LIKE RECEPTOR 4; ARMADILLO DOMAIN PROTEIN; CYTOKINE; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; SARM PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; DIAPEDESIS; ENDOTOXIN INDUCED UVEITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIFLUORESCENCE MICROSCOPY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOBLOTTING; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; LEUKOCYTE ROLLING; MOUSE; NONHUMAN; PRIORITY JOURNAL; UVEITIS; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; ESCHERICHIA COLI; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; LEUKOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ARMADILLO DOMAIN PROTEINS; CYTOKINES; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTRAVITREAL INJECTIONS; LEUKOCYTE COUNT; LEUKOCYTES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; TOLL-LIKE RECEPTOR 4; UVEITIS;

EID: 80054688303     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7742     Document Type: Article

References (37)

1. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491-500.
2. Rosenbaum JT, Nozik RA. Uveitis: many diseases, one diagnosis. Am J Med. 1985;79:545-547.
3. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxininduced uveitis in rats as a model for human disease. Nature. 1980;286:611-613.
4. Li Q, Peng B, Whitcup SM, Jang SU, Chan C-C. Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res 1995;61:629-632.
5. Planck SR, Becker MD, Crespo S, et al. Characterizing extravascular neutrophil migration in vivo in the iris. Inflammation. 2008;31: 105-111.
6. Becker MD, Garman K, Whitcup SM, Planck SR, Rosenbaum JT. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2001;42:2563-2566.
7. Rosenzweig HL, Martin TM, Planck SR, et al. Activation of NOD2 in vivo induces IL-1 beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling. J Leukoc Biol. 2008;84:529-536.
8. Becker MD, Nobiling R, Planck SR, Rosenbaum JT. Digital videoimaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis. J Immunol Methods. 2000;240:23-37.
9. Rosenzweig HL, Martin TM, Jann MM, et al. NOD2, the gene responsible for familial granulomatous uveitis, is essential in a mouse model of muramyl dipeptide-induced uveitis. Invest Ophthalmol Vis Sci. 2008;49:1518-1524.
10. Rosenzweig H, Galster K, Planck S, Rosenbaum J. NOD1 expression in the eye and functional contribution to IL-1{beta} dependent ocular inflammation in mice. Invest Ophthalmol Vis Sci. 2009;50: 1746-1753.
11. Smith JR, Subbarao K, Franc DT, Haribabu B, Rosenbaum JT. Susceptibility to endotoxin induced uveitis is not reduced in mice deficient in BLT1, the high affinity leukotriene B4 receptor. Br J Ophthalmol. 2004;88:273-275.
12. Planck SR, Han YB, Park JM, O'Rourke L, Gutierrez-Ramos J-C, Rosenbaum JT. The effect of genetic deficiency of adhesion molecules on the course of endotoxin-induced uveitis. Curr Eye Res. 1998;17:941-946.
13. van 't Veer C, van den Pangaart PS, van Zoelen MA, et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol. 2007;179:7110-7120.
14. Xiong Y, Qiu F, Piao W, Song C, Wahl LM, Medvedev AE. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-{beta}-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated Factor 6, and I{kappa}B kinase {gamma} and increases A20 expression. J Biol Chem. 2011;286:7905-7916.
15. Rosenbaum JT, Hartiala KT, Webster RO, Howes EL Jr, Goldstein IM. Antiinflammatory effects of endotoxin: inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5) derived peptides in vivo and in vitro. Am J Pathol. 1983;113:291-299.
16. Akira S. TLR signaling. Curr Topics Microbiol Immunol. 2006;311: 1-16.
17. Garcia-Ortiz H, Velazquez-Cruz R, Espinosa-Rosales F, Jimenez-Morales S, Baca V, Orozco L. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis. 2010;69: 1861-1865.
18. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359-2364.
19. van der Heijden IM, Wilbrink B, Tchetverikov I, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arth Rheum. 2000; 43:593-598.
20. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol. 2010;6:727-730.
21. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19-20.
22. Khan AI, Heit B, Andonegui G, Colarusso P, Kubes P. Lipopolysaccharide: a p38 MAPK-dependent disrupter of neutrophil chemotaxis. Microcirculation. 2005;12:421-432.
23. Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes. J Immunol. 1986;137:1971-1976.
24. Sheedy FJ, O'Neill LAJ. The troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. J Leukoc Biol. 2007;82:196-203.
25. Strengell M, Lehtonen A, Matikainen S, Julkunen I. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. J Leukoc Biol. 2006;79:1279-1285.
26. Chen X, Zhao Y, Wu X, Qian G. Enhanced expression of single immunoglobulin Il-1 receptor-related molecule ameliorates lipopolysaccharide-induced acute lung injury in mice. Shock. 2010;35: 198-204.
27. Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2007;48:3253-3259.
28. Jacob CO, McDevitt HO. Tumor necrosis factor-a in murine autoimmune "lupus" nephritis. Nature. 1988;331:356-357.
29. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 1997;17:483-490.
30. Rosenzweig HL, Minami M, Lessov NS, et al. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J Cereb Blood Flow Metab. 2007;27:1663-1674.
31. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis?-a registry-based study. Arthritis Rheum. 2007;56:3248-3252.
32. Suhler EB, Smith JR, Wertheim MS, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol. 2005;123:903-912.
33. Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 2008;59:996-1001.
34. Rosenbaum JT, Han YB, Park JM, Kennedy M, Planck SR. Tumor necrosis factor alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice. J Rheumatol. 1998;25:2408-2416.
35. Kasner L, Chan C-C, Whitcup SM, Gery I. The paradoxical effect of tumor necrosis factor alpha (TNFà) in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1993;34:2911-2917.
36. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-b as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32: 2201-2211.
37. Espevik T, Figari IS, Shalaby MR, et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med. 1987;166:571-576.